HIGHLIGHTS
- who: Xiyun Deng and colleagues from the Centre, Australia Key Laboratory of Translational Stem Cell Research, Hunan Normal University School of have published the research: Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy, in the Journal: (JOURNAL)
- how: In this Research Topic Wang et_al demonstrated that Ki67 in combination with the TIL level can be used as a biomarker to predict the outcomes of TNBC patients with residual disease after neoadjuvant chemotherapy.
- future: Perspectives Owing to the unique biological features and the aggressive clinical behavior of TNBC more robust therapeutic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.